News | July 03, 2023
Sanofi reaffirms ambition to deliver >€10bn in annual vaccines sales by 2030
Intent to start at least 5 innovative Phase 3 vaccine programs by 2025
Intent to start at least 5 innovative Phase 3 vaccine programs by 2025
Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands
Panacea Biotec has announced the launch of its new range of high-quality pediatric food & nutritional products
Injectafer is now the first and only intravenous (IV) iron replacement therapy indicated for adult patients with heart failure who have iron deficiency
Operating EBITDA increased by 21% to INR 181 crores in Q4 FY23
The addition of these two hospitals will provide increased access to specialized pediatric and perinatal care services in the geography
It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
A special technique of jet injection is used to make vaccination almost painless and totally needleless.
Subscribe To Our Newsletter & Stay Updated
